In December 2021, the Danish Parliament decided to extend the existing medicinal cannabis pilot program. As a consequence of the extension, all licenses in the pilot program must be re-issued, and application forms for both imported and Danish-grown products will be significantly updated. Further, the amendments entail that the medicinal cannabis pilot program is extended for four years so that the pilot program now applies until 31 December 2025. As a result of the new amendments, the possibility for companies to grow and manufacture cannabis for medical use has now been made permanent.
By the end of 2024, the Danish Ministry of Health will once again re-evaluate the Danish medicinal cannabis pilot program.
The amended legislation can be accessed here and here.
If you have any questions about the pilot program or other cannabis-related issues, please feel free to contact us.
Related news
Lundgrens wins complex case centered around misappropriation of trade secrets and breaches of the Marketing Practices Act
Lundgrens ranked as Top Tier Firm by IP Stars
